Protocolos de acceso expandido
de Parálisis Cerebral y Autismo
1/160 niños
en el mundo tienen autismo
1/300 nacidos vivos
tienen Parálisis Cerebral
1/45 nacidos prematuros
tienen Parálisis Cerebral
La Universidad de Duke en Octubre de 2017 lanzó el Primer programa de acceso ampliado con Células Madre de Sangre de Cordón Umbilical para Parálisis Cerebral y Autismo que permite a los niños con estos trastornos recibir el tratamiento con su propia unidad de Sangre de Cordón Umbilical.
Al ser un protocolo de acceso ampliado permite que un paciente con una enfermedad grave, que no ha encontrado una terapia eficaz para su condición, tenga la posibilidad de usar un producto médico que se ha demostrado que es seguro pero que no ha sido comercializado por el momento.
A través del convenio con FAMICORD nuestros clientes pueden acceder al programa de tratamiento de acceso ampliando basado en protocolo de la Universidad de Duke.
Ensayos Clínicos
El potencial de las Células Madre de Sangre de Cordón Umbilical en la medicina regenerativa están en constante estudio. Te mostramos las últimas novedades científicas.
| Codigo NCT | Categoria | Fases | Estatus | Localizacion | URL |
|---|---|---|---|---|---|
| NCT03735277 | Accidente Cerebro Vascular | Fase 1 | No recluta aún | Estados Unidos | https://ClinicalTrials.gov/show/NCT03735277 |
| NCT03004976 | Accidente Cerebro Vascular | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT03004976 |
| NCT03913312 | Leucemia mieloide Aguda | Fase 1|Fase 2 | Reclutando | China | https://ClinicalTrials.gov/show/NCT03913312 |
| NCT03431480 | Síndrome del corazón izquierdo hipoplásico | Fase 1 | Reclutando | Australia | https://ClinicalTrials.gov/show/NCT03431480 |
| NCT01856049 | Síndrome del corazón izquierdo hipoplásico | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01856049 |
| NCT03441958 | Mieloma Multiple | Fase 1|Fase 2 | Reclutando | Canada | https://ClinicalTrials.gov/show/NCT03441958 |
| NCT01451502 | Trastorno linfatico | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01451502 |
| NCT04172181 | SCID | N/A | Activo, no recluta | China | https://ClinicalTrials.gov/show/NCT04172181 |
| NCT04170192 | Enfermedad Inflamatoria Intestinal | N/A | Activo, no recluta | China | https://ClinicalTrials.gov/show/NCT04170192 |
| NCT04420494 | Citopenia | N/A | Reclutando | China | https://ClinicalTrials.gov/show/NCT04420494 |
| NCT03526588 | Enfermedad congenita | Fase 1 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03526588 |
| NCT02434965 | Encefalopatía hipóxico-isquémica | Fase 2 | No recluta aún | Estados Unidos | https://ClinicalTrials.gov/show/NCT02434965 |
| NCT01861093 | Anemia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01861093 |
| NCT01861093 | Leucemia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01861093 |
| NCT01861093 | Mielodisplasia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01861093 |
| NCT01861093 | Linfoma | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01861093 |
| NCT04243382 | Autismo | Fase 2 | No recluta aún | Israel | https://ClinicalTrials.gov/show/NCT04243382 |
| NCT04007224 | Autismo | Fase 1 | Solo con invitación | Rumania | https://ClinicalTrials.gov/show/NCT04007224 |
| NCT03084861 | Queratitis neurotrófica | Fase 1|Fase 2 | Reclutando | España | https://ClinicalTrials.gov/show/NCT03084861 |
| NCT02551003 | Encefalopatía hipóxico-isquémica | Fase 1|Fase 2 | Reclutando | China | https://ClinicalTrials.gov/show/NCT02551003 |
| NCT02745717 | Anemia | Phase 4 | Reclutando | China | https://ClinicalTrials.gov/show/NCT02745717 |
| NCT03087110 | Paralisis cerebral | Fase 1 | Activo, no recluta | Australia | https://ClinicalTrials.gov/show/NCT03087110 |
| NCT02455830 | Encefalopatía hipóxico-isquémica | N/A | Activo, no recluta | Japon | https://ClinicalTrials.gov/show/NCT02455830 |
| NCT01553461 | Mielodisplasia | Fase 1|Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01553461 |
| NCT01553461 | Anemia | Fase 1|Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01553461 |
| NCT04040127 | Dental | Fase 2 | No recluta aún | Estados Unidos | https://ClinicalTrials.gov/show/NCT04040127 |
| NCT04440670 | Trastorno Mental | Fase 3 | No recluta aún | China | https://ClinicalTrials.gov/show/NCT04440670 |
| NCT03881774 | Linfoma | Fase 1 | Reclutando | China | https://ClinicalTrials.gov/show/NCT03881774 |
| NCT04243408 | Paralisis cerebral | Fase 2 | No recluta aún | Israel | https://ClinicalTrials.gov/show/NCT04243408 |
| NCT03871972 | Síndrome de Hutchinson Gilford | Fase 1|Fase 2 | Solo con invitación | Corea | https://ClinicalTrials.gov/show/NCT03871972 |
| NCT03696745 | Daño cerebral | Fase 1 | No recluta aún | China | https://ClinicalTrials.gov/show/NCT03696745 |
| NCT01768845 | Leucemia | N/A | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01768845 |
| NCT01768845 | Linfoma | N/A | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01768845 |
| NCT01768845 | Anemia | N/A | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01768845 |
| NCT03130816 | Paralisis cerebral | Fase 1|Fase 2 | Activo, no recluta | Korea | https://ClinicalTrials.gov/show/NCT03130816 |
| NCT01351545 | Leucemia | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01351545 |
| NCT01351545 | Linfoma | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01351545 |
| NCT01351545 | Anemia | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01351545 |
| NCT01351545 | Desorden del Sistema Inmune | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01351545 |
| NCT01351545 | Desorden Metabolico | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01351545 |
| NCT02103296 | Anemia | N/A | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT02103296 |
| NCT01247701 | Trastronos Hematológicos | N/A | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01247701 |
| NCT00604201 | Mielodisplasia | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00604201 |
| NCT00604201 | Anemia | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00604201 |
| NCT00739141 | Leucemia | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00739141 |
| NCT00739141 | Linfoma | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00739141 |
| NCT00739141 | Mielodisplasia | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00739141 |
| NCT00950846 | Defecto congénito | N/A | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00950846 |
| NCT03913026 | Trastronos Hematológicos | Fase 2 | Reclutando | Canada | https://ClinicalTrials.gov/show/NCT03913026 |
| NCT03352310 | Encefalopatía hipóxico-isquémica | Fase 1 | Reclutando | China | https://ClinicalTrials.gov/show/NCT03352310 |
| NCT02932826 | Diabetes Tipo 1 | Fase 1|Fase 2 | Reclutando | China | https://ClinicalTrials.gov/show/NCT02932826 |
| NCT01883076 | Síndrome del corazón izquierdo hipoplásico | Fase 1 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01883076 |
| NCT03473301 | Paralisis cerebral | Fase 1|Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT03473301 |
| NCT02433509 | Accidente Cerebro Vascular | Fase 1 | Reclutando | China | https://ClinicalTrials.gov/show/NCT02433509 |
| NCT03779711 | Síndrome del corazón izquierdo hipoplásico | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03779711 |
| NCT02730299 | Leucemia | Fase 3 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT02730299 |
| NCT02730299 | Linfoma | Fase 3 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT02730299 |
| NCT02730299 | Mielodisplasia | Fase 3 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT02730299 |
| NCT01332006 | Neoplasia hematologica | Fase 2 | Reclutando | Italia | https://ClinicalTrials.gov/show/NCT01332006 |
| NCT01962636 | Leucemia | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01962636 |
| NCT01962636 | Linfoma | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01962636 |
| NCT01962636 | Mieloma | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01962636 |
| NCT01962636 | Mielodisplasia | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01962636 |
| NCT03096782 | Leucemia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03096782 |
| NCT03096782 | Linfoma | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03096782 |
| NCT03096782 | Mielodisplasia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03096782 |
| NCT03483324 | Leucemia | Fase 1 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03483324 |
| NCT03483324 | Mielodisplasia | Fase 1 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03483324 |
| NCT01597778 | Linfoma | Fase 3 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01597778 |
| NCT01597778 | Leucemia | Fase 3 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01597778 |
| NCT01690520 | Leucemia | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01690520 |
| NCT01690520 | Linfoma | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01690520 |
| NCT01619761 | Leucemia | Fase 1 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01619761 |
| NCT01619761 | Linfoma | Fase 1 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01619761 |
| NCT01619761 | Mieloma | Fase 1 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01619761 |
| NCT01619761 | Mielodisplasia | Fase 1 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01619761 |
| NCT04013646 | Accidente Cerebro Vascular | Fase 1|Fase 2 | Reclutando | Corea | https://ClinicalTrials.gov/show/NCT04013646 |
| NCT04083170 | Leucemia | Fase 2 | No recluta aún | Estados Unidos | https://ClinicalTrials.gov/show/NCT04083170 |
| NCT04083170 | VIH | Fase 2 | No recluta aún | Estados Unidos | https://ClinicalTrials.gov/show/NCT04083170 |
| NCT04083170 | Mielodisplasia | Fase 2 | No recluta aún | Estados Unidos | https://ClinicalTrials.gov/show/NCT04083170 |
| NCT03979742 | Lesion Medula Espinal | Fase 2 | No recluta aún | Estados Unidos | https://ClinicalTrials.gov/show/NCT03979742 |
| NCT02881970 | Encefalopatía hipóxico-isquémica | Fase 1|Fase 2 | No recluta aún | Francia | https://ClinicalTrials.gov/show/NCT02881970 |
| NCT03885947 | Leucemia | Fase 1 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03885947 |
| NCT03885947 | Linfoma | Fase 1 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03885947 |
| NCT03885947 | Mielodisplasia | Fase 1 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03885947 |
| NCT02727803 | Leucemia | Reclutando | China | https://clinicaltrials.gov/ct2/show/NCT02727803 | |
| NCT03016806 | Trastorno hematologico | Fase 1 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03016806 |
| NCT03016806 | Trastorno metabolico | Fase 1 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03016806 |
| NCT03016806 | Anemia | Fase 1 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03016806 |
| NCT02140944 | HIV | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT02140944 |
| NCT03835312 | Diabetes Tipo 1 | N/A | Reclutando | China | https://ClinicalTrials.gov/show/NCT03835312 |
| NCT04103879 | Trastornos hematologicos | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT04103879 |
| NCT01996228 | Diabetes Tipo 1 | Fase 1|Fase 2 | Reclutando | China | https://ClinicalTrials.gov/show/NCT01996228 |
| NCT04393415 | COVID-19 | N/A | No recluta aún | Egipto | https://ClinicalTrials.gov/show/NCT04393415 |
| NCT01300611 | Leucemia | Fase 1 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01300611 |
| NCT01300611 | Linfoma | Fase 1 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01300611 |
| NCT03011021 | Diabetes Tipo 1 | Fase 1|Fase 2 | Reclutando | China | https://ClinicalTrials.gov/show/NCT03011021 |
| NCT01682226 | Leucemia | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01682226 |
| NCT01682226 | Linfoma | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01682226 |
| NCT01682226 | Mielodisplasia | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01682226 |
| NCT03173937 | Anemia | Fase 1|Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03173937 |
| NCT03173937 | Mielodisplasia | Fase 1|Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03173937 |
| NCT00719888 | Leucemia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT00719888 |
| NCT00719888 | Linfoma | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT00719888 |
| NCT00719888 | Mielodisplasia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT00719888 |
| NCT00719888 | Anemia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT00719888 |
| NCT03739502 | Leucemia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03739502 |
| NCT03739502 | Linfoma | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03739502 |
| NCT03739502 | Mielodisplasia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03739502 |
| NCT03826498 | Paralisis cerebral | Fase 2 | Activo, no recluta | Rusia | https://ClinicalTrials.gov/show/NCT03826498 |
| NCT03093844 | Trastorno hematologico | N/A | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT03093844 |
| NCT00796068 | Leucemia | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00796068 |
| NCT00796068 | Mielodisplasia | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00796068 |
| NCT00305682 | Leucemia | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00305682 |
| NCT00305682 | Linfoma | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00305682 |
| NCT00305682 | Mielodisplasia | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00305682 |
| NCT02955550 | Mieloma | Fase 1 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT02955550 |
| NCT03019640 | Linfoma | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03019640 |
| NCT03558269 | trastorno neonatal | Fase 1|Fase 2 | Reclutando | Israel | https://ClinicalTrials.gov/show/NCT03558269 |
| NCT03558269 | trastorno cardiaco congenito | Fase 1|Fase 2 | Reclutando | Israel | https://ClinicalTrials.gov/show/NCT03558269 |
| NCT01729091 | Leucemia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01729091 |
| NCT01729091 | Mieloma | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01729091 |
| NCT02280525 | Leucemia | Fase 1 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT02280525 |
| NCT00547196 | Leucemia | N/A | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00547196 |
| NCT00547196 | Linfoma | N/A | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00547196 |
| NCT00547196 | Mielodisplasia | N/A | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00547196 |
| NCT04099381 | Autismo | Fase 1|Fase 2 | Reclutando | Rusia | https://ClinicalTrials.gov/show/NCT04099381 |
| NCT03056339 | Leucemia | Fase 1|Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03056339 |
| NCT03056339 | Linfoma | Fase 1|Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03056339 |
| NCT03802773 | Trastorno hematologico | Reclutando | Italia | https://ClinicalTrials.gov/show/NCT03802773 | |
| NCT03594981 | Inmunoterapia antiviral | Fase 1|Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03594981 |
| NCT03876821 | Anemia | N/A | No recluta aún | Estados Unidos | https://ClinicalTrials.gov/show/NCT03876821 |
| NCT03941769 | Leucemia | Fase 1 | No recluta aún | Estados Unidos | https://ClinicalTrials.gov/show/NCT03941769 |
| NCT03941769 | Mielodisplasia | Fase 1 | No recluta aún | Estados Unidos | https://ClinicalTrials.gov/show/NCT03941769 |
| NCT02181478 | Leucemia | Early Phase 1 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT02181478 |
| NCT02181478 | Linfoma | Early Phase 1 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT02181478 |
| NCT02181478 | Mielodisplasia | Early Phase 1 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT02181478 |
| NCT03434730 | Leucemia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03434730 |
| NCT03434730 | Linfoma | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03434730 |
| NCT03434730 | Mielodisplasia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03434730 |
| NCT02508324 | Leucemia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT02508324 |
| NCT02508324 | Mielodisplasia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT02508324 |
| NCT04003857 | Displasia broncopulmonar | Fase 2 | Reclutando | Corea | https://ClinicalTrials.gov/show/NCT04003857 |
| NCT01897987 | Displasia broncopulmonar | Fase 2 | Reclutando | Corea | https://ClinicalTrials.gov/show/NCT01897987 |
| NCT03420963 | Tumores solidos | Fase 1 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03420963 |
| NCT02722668 | leucemia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT02722668 |
| NCT02722668 | Linfoma | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT02722668 |
| NCT01350219 | Diabetes Tipo 1 | Fase 2 | Reclutando | España | https://ClinicalTrials.gov/show/NCT01350219 |
| NCT01927731 | Fallo Medular | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01927731 |
| NCT01632475 | Displasia broncopulmonar | N/A | Activo, no recluta | Corea | https://ClinicalTrials.gov/show/NCT01632475 |
| NCT02254863 | Trastorno metabolico | Fase 1 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT02254863 |
| NCT01586455 | Trastorno metabolico | Fase 1 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01586455 |
| NCT00919503 | Trastorno hematologico | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT00919503 |
| NCT03855202 | Displasia broncopulmonar | Fase 1 | No recluta aún | China | https://ClinicalTrials.gov/show/NCT03855202 |
| NCT03773393 | Fallo Medular | Fase 1 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03773393 |
| NCT03773328 | Sindrome Guillain-Barré | Fase 1 | No recluta aún | Estados Unidos | https://ClinicalTrials.gov/show/NCT03773328 |
| NCT03392467 | Displasia broncopulmonar | Fase 2 | Reclutando | Corea | https://ClinicalTrials.gov/show/NCT03392467 |
| NCT02423915 | leucemia | Fase 1|Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT02423915 |
| NCT02423915 | linfoma | Fase 1|Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT02423915 |
| NCT03719534 | Trastornos hematologicos | N/A | Reclutando | China | https://ClinicalTrials.gov/show/NCT03719534 |
| NCT00357565 | leucemia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT00357565 |
| NCT00357565 | Mielodisplasia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT00357565 |
| NCT00357565 | Anemia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT00357565 |
| NCT02046291 | Trastornos hematologicos | Fase 1 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT02046291 |
| NCT01590628 | Anemia | Fase 1|Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01590628 |
| NCT01590628 | Talasemia | Fase 1|Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01590628 |
| NCT01962415 | Fallo Medular | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01962415 |
| NCT01962415 | Anemia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01962415 |
| NCT01962415 | Trastorno metabolico | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01962415 |
| NCT00408447 | Anemia | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00408447 |
| NCT00408447 | Talasemia | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00408447 |
| NCT03406962 | Trastorno metabolico | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT03406962 |
| NCT03158896 | Injerto contra huesped (GVHD) | Fase 1 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT03158896 |
| NCT04098029 | Paralisis cerebral | Fase 2 | Reclutando | Rusia | https://ClinicalTrials.gov/show/NCT04098029 |
| NCT03634501 | Tumores solidos | Fase 1|Fase 2 | Reclutando | China | https://ClinicalTrials.gov/show/NCT03634501 |
| NCT01810588 | Trastornos hematologicos | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01810588 |
| NCT04260698 | Trastornos hematologicos | Fase 3 | No recluta aún | Estados Unidos | https://ClinicalTrials.gov/show/NCT04260698 |
| NCT04324996 | COVID-19 | Fase 1|Fase 2 | Reclutando | China | https://ClinicalTrials.gov/show/NCT04324996 |
| NCT04418557 | COVID-19 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT04418557 | |
| NCT02251821 | Mielofibrosis | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT02251821 |
| NCT03635450 | Encefalopatía hipóxico-isquémica | Fase 1 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT03635450 |
| NCT04379284 | COVID-19 | No recluta aún | Estados Unidos | https://ClinicalTrials.gov/show/NCT04379284 | |
| NCT00012545 | Anemia | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT00012545 | |
| NCT04360811 | COVID-19 | N/A | Reclutando | Francia | https://ClinicalTrials.gov/show/NCT04360811 |
| NCT01020539 | Leucemia | Fase 1 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01020539 |
| NCT01020539 | Mielodisplasia | Fase 1 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01020539 |
| NCT03752372 | Enfermedad Inflamatoria Intestinal | Activo, no recluta | China | https://ClinicalTrials.gov/show/NCT03752372 | |
| NCT03378063 | Displasia broncopulmonar | Early Phase 1 | Reclutando | China | https://ClinicalTrials.gov/show/NCT03378063 |
| NCT04347616 | Leucemia | Fase 1|Fase 2 | No recluta aún | Holanda | https://ClinicalTrials.gov/show/NCT04347616 |
| NCT01174875 | Trastorno Mental | N/A | Activo, no recluta | Singapur | https://ClinicalTrials.gov/show/NCT01174875 |
| NCT01174875 | Trastorno Metabolico | N/A | Activo, no recluta | Singapur | https://ClinicalTrials.gov/show/NCT01174875 |
| NCT02948179 | Trastorno Genético | N/A | Reclutando | China | https://ClinicalTrials.gov/show/NCT02948179 |
| NCT02065596 | Anemia | Fase 1|Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT02065596 |
| NCT01050855 | Inmunodeficiencia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01050855 |
| NCT04140747 | Colonizacion Microbiana | N/A | Reclutando | Austria | https://ClinicalTrials.gov/show/NCT04140747 |
| NCT02184676 | Diabetes Tipo 1 | N/A | Activo, no recluta | Francia | https://ClinicalTrials.gov/show/NCT02184676 |
| NCT04213131 | Lesion Medula Espinal | N/A | Reclutando | China | https://ClinicalTrials.gov/show/NCT04213131 |
| NCT02179359 | Anemia | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT02179359 |
| NCT02179359 | Sindrome Shwachman-Diamond | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT02179359 |
| NCT02179359 | Talasemia | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT02179359 |
| NCT02179359 | Trombastenia de Glanzmann | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT02179359 |
| NCT02179359 | Fallo Medular | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT02179359 |
| NCT03904134 | Leucemia | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03904134 |
| NCT03904134 | Linfoma | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03904134 |
| NCT03904134 | Anemia | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03904134 |
| NCT00574496 | Linfoma | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00574496 |
| NCT00550992 | Leucemia | N/A | Reclutando | Alemania, Italia, Australia, Nueva zelanda, Francia, Austria, Portugal, Belgica, Chile, Polinia, Estados Unidos, Reino Unido | https://ClinicalTrials.gov/show/NCT00550992 |
| NCT03513328 | Trastorno Hereditario | Fase 1|Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03513328 |
| NCT03513328 | Anemia | Fase 1|Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03513328 |
| NCT03513328 | Fallo Medular | Fase 1|Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03513328 |
| NCT03513328 | Talasemia | Fase 1|Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03513328 |
| NCT01033552 | Epidermolisis Bullosa | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01033552 |
| NCT00352976 | Anemia | Fase 2|Fase 3 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT00352976 |
| NCT01366092 | Enfermedad injerto contra Huesped (GVHD) | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01366092 |
| NCT03393611 | Leucemia | Fase 1 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03393611 |
| NCT03393611 | Mielodisplasia | Fase 1 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03393611 |
| NCT01685411 | Leucemia | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01685411 |
| NCT01685411 | Mielodisplasia | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01685411 |
| NCT04008849 | Desorden Metabolico | N/A | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT04008849 |
| NCT00630253 | Anemia | Fase 1|Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT00630253 |
| NCT00258427 | Anemia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT00258427 |
| NCT04353544 | Hemorragia post parto | N/A | Reclutando | Italia | https://ClinicalTrials.gov/show/NCT04353544 |
| NCT01652092 | Trastorno Hereditario | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01652092 |
| NCT04369313 | Diabetes Tipo 1 | N/A | Reclutando | China | https://ClinicalTrials.gov/show/NCT04369313 |
| NCT04369313 | Asfixia neonatal | N/A | Reclutando | China | https://ClinicalTrials.gov/show/NCT04369313 |
| NCT02878850 | Lesion Medula Espinal | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT02878850 |
| NCT04395924 | COVID-19 | Reclutando | Francia | https://ClinicalTrials.gov/show/NCT04395924 | |
| NCT00913471 | Lesion Medula Espinal | N/A | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00913471 |
| NCT02396823 | Lesion Medula Espinal | N/A | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT02396823 |
| NCT03949660 | Disfunción intestinal neurógena | N/A | No recluta aún | Estados Unidos | https://ClinicalTrials.gov/show/NCT03949660 |
| NCT03681314 | Encefalopatía hipóxico-isquémica | N/A | No recluta aún | India | https://ClinicalTrials.gov/show/NCT03681314 |
| NCT03682042 | Encefalopatía hipóxico-isquémica | N/A | No recluta aún | India | https://ClinicalTrials.gov/show/NCT03682042 |
| NCT03859037 | Sufrimiento fetal | N/A | No recluta aún | Egipto | https://ClinicalTrials.gov/show/NCT03859037 |
| NCT02893553 | Lesion Medula Espinal | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT02893553 |
| NCT03621943 | Trastono neuronal | N/A | Reclutando | Canada | https://ClinicalTrials.gov/show/NCT03621943 |
| NCT03690700 | Lesion Medula Espinal | N/A | No recluta aún | Dinamarca | https://ClinicalTrials.gov/show/NCT03690700 |
| NCT03621956 | Asfixia neonatal | N/A | Reclutando | Canada | https://ClinicalTrials.gov/show/NCT03621956 |
| NCT03505463 | Lesion Medula Espinal | N/A | Reclutando | Dinamarca | https://ClinicalTrials.gov/show/NCT03505463 |
| NCT03657394 | Encefalopatía hipóxico-isquémica | Fase 3 | No recluta aún | India | https://ClinicalTrials.gov/show/NCT03657394 |
| NCT03998527 | Lesion Medula Espinal | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03998527 |
| NCT02859792 | Lesion Medula Espinal | Fase 2 | No recluta aún | Francia | https://ClinicalTrials.gov/show/NCT02859792 |